We apologize for the inconvenience

The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

You will be automatically re-directed to People Search on yellowpages.com in .

Please note our privacy policy has changed. To view the policy, please go to https://corporate.thryv.com/privacy/

Details

General Info

Dr. Freedberg graduated from Harvard Medical School and completed his residency and fellowship training at Columbia University. He received a Master's degree in biostatistics from Columbia's Mailman School of Public Health. Dr. Freedberg's research focuses on the use of acid suppression medications, Clostridium difficile infection, and the gastrointestinal microbiome. Current projects include studies of how acid suppression medications alter the colonic microbiome and of how alterations in the gastrointestinal flora predispose patients to Clostridium difficile and other infections during periods of critical illness. His research is funded by the National Institutes of Health and the American Gastroenterological Association. Dr. Freedberg is a clinical and translational investigator focused on the relationship between the gastrointestinal microbiome and infections, both enteric and non-enteric. He is a graduate of Harvard Medical School and the Mailman School of Public Health and trained in medicine and gastroenterology at Columbia University Medical Center. He is the past recipient of an American Gastroenterological Association (AGA) Research Scholar Award and has received funding from the NIH/NIDDK, Irving Institute (Columbia's CTSA), and the Department of Defense. His work has been published in leading journals across disciplines: Gastroenterology, Clinical Infectious Disease, Intensive Care Medicine, JAMA Internal Medicine, and Nature. Currently, he focuses on the gastrointestinal microbiome in the intensive care unit (ICU). He has built large ICU cohorts containing longitudinal clinical data, serial rectal swabs, other biosamples, and clinical outcomes data. These samples and data have been collected to understand the dynamic changes that take place within the gastrointestinal microbiome during critical illness and to ask how these changes may impact risk for ICU-acquired infections. His past studies in this area show the importance of colonizing pathogens such as C. difficile and vancomycin-resistant Enterococcus (VRE) as determinants not only of the patient's own health but of outcomes for patients who share the same hospital environment. Ongoing research tests interventions seeking to improve the resistance of the native gut microbiota against pathogens, with a goal of preventing colonization and downstream infection in the ICU.

Contact Info

Phone:

Main - 646-317-3533

Address:
161 Fort Washington Ave New York, NY 10032

Reviews

Be the first to review!
Write a Review
Categories
Physicians & Surgeons, Physicians & Surgeons, Gastroenterology (Stomach & Intestines), Physicians & Surgeons, Internal Medicine
Location
Herbert Irving Pavilion
Other Information

Specialties: Internal Medicine, Gastroenterology

Provided by
Data provided by one or more of the following: Thryv, Data Axle, Yext.